中药牛贝消核对小鼠结核模型的治疗作用
该研究以感染结核分枝杆菌H37Rv的120只雌性BALB/c小鼠为对象,比较牛贝消核散剂(I)及三种提取物(II、III、IV)不同剂量与母牛分枝杆菌疫苗的疗效。结果显示各牛贝消核组体重均高于水对照组,部分组脾脏重量指数和脾脏菌落数显著降低(P<0.05),但各组肺脏菌落数无显著差异,肺部病变有不同程度改善。
要点
- 牛贝消核散剂及三种提取物对小鼠结核模型均显示抗结核治疗作用。
- 部分牛贝消核组脾脏菌落数较水对照组显著降低,但肺脏菌落数组间无显著差异。
- 低剂量NBXH III和IV组肺部病变面积小于50%,半数小鼠可见一半正常肺结构。
核心结论
- 牛贝消核的散剂和三种提取物对小鼠结核模型均具有抗结核治疗作用,为其中成药开发提供了基础。
研究设计与样本
- 研究使用120只感染结核分枝杆菌H37Rv的雌性BALB/c小鼠,分别给予蒸馏水、母牛分枝杆菌疫苗、牛贝消核I、II、III、IV的低、中、高剂量,治疗12周。
主要发现
- 所有牛贝消核组小鼠体重均高于水对照组。
- 母牛分枝杆菌组、NBXH II中剂量组、NBXH IV低剂量组和高剂量组的脾脏重量指数显著低于水对照组(P<0.05)。
- 与水对照组相比,NBXH I低剂量组、NBXH II高剂量组、NBXH III低剂量组和NBXH IV高剂量组的脾脏菌落数分别减少0.43、0.46、0.73、0.58 logs(P<0.05)。
- 各组肺脏菌落数无显著差异。
- 肺部大体病理和组织病理显示治疗组肺部病变有不同程度改善,尤其NBXH III和IV低剂量组病变面积小于50%,半数小鼠可见一半正常肺结构。
临床怎么用
- 牛贝消核不同加工品在小鼠结核模型中显示治疗作用,但肺脏菌落数未见显著降低,临床转化需进一步研究。
局限性
- 研究仅在小鼠模型中进行,样本量有限,肺脏菌落数未显示显著差异,临床疗效尚需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The traditional Chinese medicine Niubeixiaohe (NBXH) is an effective anti-tuberculosis prescription, which is made up of Bulbus Fritillariae Cirrhosae, Rhizoma Bletillae, Radix Platycodonis, Fructus Arctii, Herba Houttuyniae and Glutinous rice. In this study, NBXH powder (I) and three kinds of NBXH extracts (II, III, and IV) were prepared. The water decoction of NBXH had been used to treat TB in clinic sixteen years suggested that it was effective to treat TB. AIM OF THE STUDY: This study evaluated the effects of different processing products of NBXH on mouse TB model in vivo and provide a new Chinese medicine for the clinical treatment of TB. MATERIALS AND METHODS: In this study, 120 female BALB/c mice infected with Mycobacterium tuberculosis H37Rv, were treated with distilled water, M. vaccae vaccine, the low, middle and high doses of NBXH I, the low, middle and high doses of NBXH II, the low, middle and high doses of NBXH III, the low, middle and high doses of NBXH IV for 12 weeks, respectively. RESULTS: The body weights of mice in all NBXH groups were higher than that in the water group. The weight indexes of the spleens in M. vaccae group, the middle dose of NBXH II group, the low dose of NBXH IV group and in the high dose of NBXH IV group were significantly lower than that in the water group(P<0.05). Compared with the water group, the spleen colony counts in the low dose of NBXH I group, the high dose of NBXH II group, the low dose of NBXH III group and the high dose of NBXH IV group reduced by 0.43, 0.46, 0.73, 0.58 logs (P<0.05), respectively. But the lung colony counts had no significant difference between each group. Pulmonary general pathology and histopathology displayed that the lung lesions in treatment groups were improved at certain degree, especially in the low dose of NBXH IIIand IV groups, in which their areas of the lesions were less than 50%, and the half normal lung structure in half of the mice could be observed. CONCLUSION: Powder and three extracts of traditional Chinese medicine NBXH all had anti-tuberculosis therapeutic effects on mouse tuberculosis model, and this study provided a base for the further development of Chinese patent medicine NBXH. Also, this is the first report on comprehensive experimental research of NBXH extracts coming from six kinds of traditional Chinese medicine.
引用
- Liang Y, Wang X, Song J, et al. Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models. J Ethnopharmacol. 2016. PMID: 27884716. doi:10.1016/j.jep.2016.11.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。